Miguel Coego Rios
Director of Finance/CFO bei CENTOGENE N.V.
Aktive Positionen von Miguel Coego Rios
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CENTOGENE N.V. | Director of Finance/CFO | 31.03.2022 | - |
| General Counsel | 08.02.2022 | - |
Karriereverlauf von Miguel Coego Rios
Ehemalige bekannte Positionen von Miguel Coego Rios
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SHIRE | Corporate Officer/Principal | 01.01.2011 | 01.01.2019 |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
| ORPHAZYME A/S | Corporate Officer/Principal | - | - |
Statistik
International
| Vereinigtes Königreich | 2 |
| Irland | 2 |
| Dänemark | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 1 |
| General Counsel | 1 |
Sektoral
| Health Technology | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ORPHAZYME A/S | Health Technology |
| CENTOGENE N.V. | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Börse
- Insiders
- Miguel Coego Rios
- Erfahrung
